Cargando…
COVID-19 in underlying COPD Patients
Autores principales: | Sunkara, Krishna, Allam, Venkata Raj, Shukla, Shakti D., Chellappan, Dinesh K., Gupta, Gaurav, MacLoughlin, Ronan, Dua, Kamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898043/ https://www.ncbi.nlm.nih.gov/pubmed/33628161 http://dx.doi.org/10.17179/excli2021-3322 |
Ejemplares similares
-
Female gender as a risk factor for developing COPD
por: Shukla, Shakti D., et al.
Publicado: (2021) -
Interferon therapy for preventing COPD exacerbations
por: Mehta, Meenu, et al.
Publicado: (2020) -
Editorial: Advanced therapeutic delivery for the management of chronic respiratory diseases
por: Paudel, Keshav Raj, et al.
Publicado: (2022) -
Cytotoxic mechanisms of berberine-phytantriol liquid crystalline nanoparticles against non-small-cell lung cancer
por: Paudel, Keshav Raj, et al.
Publicado: (2023) -
Recent update on barbiturate in relation to brain disorder
por: Pathak, Sachchidanand, et al.
Publicado: (2021)